Literature DB >> 10994773

Evidence for degradation of cytokines in the serum of patients with atopic dermatitis by calcium-dependent protease.

Y Niwa1, H Akamatsu, H Sumi, Y Ozaki, A Abe.   

Abstract

Changes in the levels of cytokines in the circulating blood and skin have been reported in patients with atopic dermatitis (AD). We determined IFN-gamma, IL-2, IL-4, IL-5 and IL-10 in both the serum and plasma of 45 AD patients and 20 healthy donors. Since differences in the levels of these cytokines between serum and plasma were found, the roles of Ca2+ and proteolytic enzymes were examined. Levels of IL-2 and IL-10 were measured in citrated plasma to which various amounts of CaCl2, protease inhibitors, and proteases had been added. All cytokine determinations were carried out using a standard ELISA. The plasma levels of IFN-gamma, IL-2, and IL-5 were significantly elevated, but the serum levels of these cytokines were not significantly changed. The levels of IL-2 in the plasma of the AD patients averaged 4.25-fold higher than in the serum of the AD patients, and 2.5-fold higher than in the plasma of healthy controls (P < 0.001). CaCl2 produced a dose-dependent decrease in IL-2 and IL-10 in citrated plasma. The protease inhibitors PMSF, aprotinin and leupeptin produced a dose-dependent increase in measurable levels of IL-2 and IL-10 in plasma. A decrease in IL-2 levels was also seen in CaCl2-supplemented serum-free medium, and this was accentuated by the addition of the proteases thrombin, trypsin, chymotrypsin and elastase. These findings suggest that although significant changes in cytokine levels have been reported not to occur in circulating blood but have been reported to occur in the skin of AD patients both in vivo and in vitro, cytokines can indeed also be found to be elevated in circulating blood when assessed carefully by statistically valid methods. Further, it is suggested that during the preparation of serum, some circulating cytokines are degraded by calcium-dependent proteases, and that Ca2+ itself can also affect the measurement of cytokines. The measurement of circulating cytokines needs to be carefully reassessed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10994773     DOI: 10.1007/s004030000148

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  7 in total

1.  Localized Cell-Surface Sampling of a Secreted Factor Using Cell-Targeting Beads.

Authors:  Tammi L van Neel; Samuel B Berry; Erwin Berthier; Ashleigh B Theberge
Journal:  Anal Chem       Date:  2020-10-02       Impact factor: 6.986

Review 2.  Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis.

Authors:  A Masi; D S Quintana; N Glozier; A R Lloyd; I B Hickie; A J Guastella
Journal:  Mol Psychiatry       Date:  2014-06-17       Impact factor: 15.992

Review 3.  Blood cytokines as biomarkers of in vivo toxicity in preclinical safety assessment: considerations for their use.

Authors:  Jacqueline M Tarrant
Journal:  Toxicol Sci       Date:  2010-05-06       Impact factor: 4.849

4.  Evaluation of Potential Disease-Mediated Drug-Drug Interaction in Patients With Moderate-to-Severe Atopic Dermatitis Receiving Dupilumab.

Authors:  John D Davis; Ashish Bansal; David Hassman; Bolanle Akinlade; Meng Li; Zhaoyang Li; Brian Swanson; Jennifer D Hamilton; A Thomas DiCioccio
Journal:  Clin Pharmacol Ther       Date:  2018-04-02       Impact factor: 6.875

5.  Characterization of Endocannabinoid-Metabolizing Enzymes in Human Peripheral Blood Mononuclear Cells under Inflammatory Conditions.

Authors:  Brittany N Szafran; Jung Hwa Lee; Abdolsamad Borazjani; Peter Morrison; Grace Zimmerman; Kelly L Andrzejewski; Matthew K Ross; Barbara L F Kaplan
Journal:  Molecules       Date:  2018-12-01       Impact factor: 4.411

6.  Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters.

Authors:  Filip Ventorp; Anna Gustafsson; Lil Träskman-Bendz; Åsa Westrin; Lennart Ljunggren
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

Review 7.  In vitro Models to Evaluate Drug-Induced Hypersensitivity: Potential Test Based on Activation of Dendritic Cells.

Authors:  Valentina Galbiati; Angela Papale; Elena Kummer; Emanuela Corsini
Journal:  Front Pharmacol       Date:  2016-07-12       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.